Nifty

:

16945.05

Sensex

:

57527.10

-131.85 (-0.77%)
-398.18 (-0.69%)

Login

Nifty
Sensex

:
:

16945.05
57527.10

-131.85 (-0.77%)
-398.18 (-0.69%)

Novartis India Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

64/99

BSE: 500672 | NSE: NOVARTIND

Watchlist

NSE BSE

568.85

24-Mar-2023

Day's Open
Day's High
Day's Low
Previous Close

566.35
583.20
565.00
560.80

Volume
Traded Value (lacs)
52 Week High
52 Week Low

16531
95.09
780.00
537.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,404.66
25.55
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

887.03
1.76%
1.88

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-7.83
-6.64
-3.01

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-11.73
-
16.79

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-

P:E (Median)

8 Years
5 Years
3 Years

31.94
49.67
63.93

P:BV (Average)

8 Years
5 Years
3 Years

2.31
2.31
2.33

EV:EBITDA (Average)

8 Years
5 Years
3 Years

13.07
13.97
17.18

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 22 Dec 21 Var% Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var%
Net Sales 80.17 98.96 -18.99% 101.52 104.48 -2.83% 120.92 98.11 23.25% 98.32 99.29 -0.98%
Expenses 72.53 92.40 -21.50% 85.20 97.39 -12.52% 89.12 90.27 -1.27% 92.70 84.02 10.33%
EBITDA 7.64 6.56 16.46% 16.32 7.09 130.18% 31.80 7.84 305.61% 5.62 15.27 -63.20%
EBIDTM 9.53% 6.63% 16.08% 6.79% 26.30% 7.99% 5.72% 15.38%
Other Income 8.36 6.04 38.41% 6.86 6.38 7.52% 26.52 6.46 310.53% 14.31 12.27 16.63%
Interest 0.46 1.46 -68.49% 0.49 1.50 -67.33% 0.50 1.54 -67.53% 0.33 2.72 -87.87%
Depreciation 1.30 2.75 -52.73% 1.38 2.68 -48.51% 1.30 2.91 -55.33% 1.31 2.92 -55.14%
PBT 14.24 8.39 69.73% 21.31 9.29 129.39% 56.52 9.85 473.81% -31.35 21.90 -
Tax 6.63 2.04 225.00% 2.96 2.27 30.40% 4.14 3.57 15.97% -7.98 12.20 -
PAT 7.61 6.35 19.84% 18.35 7.02 161.40% 52.38 6.28 734.08% -23.37 9.70 -
PATM 9.49% 6.42% 18.08% 6.72% 43.32% 6.40% -23.77% 9.77%
EPS 3.08 2.57 19.84% 7.43 2.84 161.62% 21.21 2.54 735.04% -9.46 3.93 -

Description Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 400.93 399.87 381.35 438.25 490.68 563.89 656.22 689.77 873.38 862.23 903.36 Net Sales Growth 0.02% 4.86% -12.98% -10.69% -12.98% -14.07% -4.86% -21.02% 1.29% -4.55% Cost Of Goods Sold 205.03 178.14 146.61 182.32 198.65 245.51 306.10 286.31 349.02 386.65 367.39 Gross Profit 195.90 221.73 234.74 255.93 292.03 318.38 350.12 403.46 524.36 475.58 535.97 GP Margin 48.86% 55.45% 61.56% 58.40% 59.52% 56.46% 53.35% 58.49% 60.04% 55.16% 59.33% Total Expenditure 339.55 374.36 355.66 426.51 478.54 572.12 631.70 658.95 881.18 865.65 814.48 Power & Fuel Cost - 0.53 0.53 1.27 1.79 2.56 1.77 4.43 4.87 4.02 3.57 % Of Sales - 0.13% 0.14% 0.29% 0.36% 0.45% 0.27% 0.64% 0.56% 0.47% 0.40% Employee Cost - 101.89 108.51 113.87 117.11 144.53 139.30 156.66 200.03 174.19 162.30 % Of Sales - 25.48% 28.45% 25.98% 23.87% 25.63% 21.23% 22.71% 22.90% 20.20% 17.97% Manufacturing Exp. - 34.49 36.52 39.23 42.21 42.07 49.03 62.35 98.47 104.52 97.61 % Of Sales - 8.63% 9.58% 8.95% 8.60% 7.46% 7.47% 9.04% 11.27% 12.12% 10.81% General & Admin Exp. - 18.61 12.95 23.40 43.28 45.74 45.74 47.65 64.48 62.19 64.16 % Of Sales - 4.65% 3.40% 5.34% 8.82% 8.11% 6.97% 6.91% 7.38% 7.21% 7.10% Selling & Distn. Exp. - 35.66 39.77 53.99 60.29 72.48 75.83 70.74 131.14 101.63 90.68 % Of Sales - 8.92% 10.43% 12.32% 12.29% 12.85% 11.56% 10.26% 15.02% 11.79% 10.04% Miscellaneous Exp. - 5.04 10.77 12.43 15.21 19.23 13.93 30.81 33.17 32.45 90.68 % Of Sales - 1.26% 2.82% 2.84% 3.10% 3.41% 2.12% 4.47% 3.80% 3.76% 3.18% EBITDA 61.38 25.51 25.69 11.74 12.14 -8.23 24.52 30.82 -7.80 -3.42 88.88 EBITDA Margin 15.31% 6.38% 6.74% 2.68% 2.47% -1.46% 3.74% 4.47% -0.89% -0.40% 9.84% Other Income 56.05 34.79 34.19 36.43 78.40 173.81 71.52 244.55 111.58 97.24 84.35 Interest 1.78 4.83 7.68 6.39 1.59 5.53 0.72 0.21 0.21 0.27 0.22 Depreciation 5.29 9.65 12.16 13.14 3.18 2.53 3.59 3.49 4.01 3.65 3.59 PBT 60.72 45.82 40.04 28.64 85.77 157.52 91.73 271.67 99.56 89.90 169.42 Tax 5.75 -0.10 19.14 18.56 34.00 79.16 34.51 73.38 14.12 -8.63 49.69 Tax Rate 9.47% 2.62% 47.80% 64.80% 39.64% 50.25% 37.62% 27.01% 15.15% -9.60% 29.33% PAT 54.97 -3.72 20.90 10.08 51.77 78.36 57.22 198.29 79.11 98.53 119.73 PAT before Minority Interest 54.97 -3.72 20.90 10.08 51.77 78.36 57.22 198.29 79.11 98.53 119.73 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 13.71% -0.93% 5.48% 2.30% 10.55% 13.90% 8.72% 28.75% 9.06% 11.43% 13.25% PAT Growth 87.29% - 107.34% -80.53% -33.93% 36.95% -71.14% 150.65% -19.71% -17.71% EPS 22.26 -1.51 8.46 4.08 20.96 31.72 23.17 80.28 32.03 39.89 48.47

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 691.70 711.19 720.73 759.19 733.64 919.64 1,193.58 1,001.99 961.35 900.21 Share Capital 12.34 12.34 12.34 12.34 12.34 14.07 15.98 15.98 15.98 15.98 Total Reserves 681.58 701.80 711.68 751.10 727.48 913.00 1,184.54 986.01 945.37 884.23 Non-Current Liabilities 999.92 1,130.65 99.38 891.47 897.75 827.53 26.47 696.64 585.68 560.05 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 1,007.50 1,109.57 65.93 909.70 916.30 844.46 45.85 714.94 600.01 572.48 Current Liabilities 334.47 357.26 416.93 367.22 481.74 323.21 204.49 361.82 458.91 492.87 Trade Payables 72.20 55.20 72.60 91.40 106.11 73.22 69.66 94.52 107.52 119.59 Other Current Liabilities 45.34 69.64 132.99 67.62 184.52 63.26 88.94 52.24 47.58 40.69 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 216.93 232.42 211.34 208.20 191.11 186.73 45.89 215.06 303.81 332.59 Total Liabilities 2,026.09 2,199.10 1,237.04 2,017.88 2,113.13 2,070.38 1,424.54 2,060.45 2,005.94 1,953.13 Net Block 23.65 63.91 76.28 14.98 4.60 5.71 6.48 8.50 7.87 9.96 Gross Block 32.94 74.81 85.08 23.93 12.09 10.82 9.87 26.08 23.98 25.74 Accumulated Depreciation 9.29 10.90 8.80 8.95 7.49 5.11 3.39 17.58 16.11 15.78 Non Current Assets 1,199.31 1,276.75 239.77 1,029.20 1,008.86 958.91 160.85 845.95 698.16 638.95 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.01 0.45 0.00 0.00 0.27 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.03 0.03 Long Term Loans & Adv. 1,148.17 1,186.01 137.84 989.61 979.98 935.98 153.29 837.20 690.13 628.60 Other Non Current Assets 27.49 26.83 25.65 24.61 24.28 17.21 0.63 0.24 0.13 0.09 Current Assets 826.78 922.35 997.27 988.68 1,104.27 1,111.47 1,263.69 1,214.50 1,307.78 1,314.18 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 57.07 47.95 58.68 60.51 56.56 87.52 72.40 99.94 103.59 110.15 Sundry Debtors 44.56 38.73 37.60 45.59 43.91 40.83 50.17 82.90 77.40 82.44 Cash & Bank 517.63 498.88 581.91 612.02 775.08 815.72 1,125.55 838.55 16.81 39.30 Other Current Assets 207.52 46.30 59.09 34.54 228.72 167.40 15.57 193.11 1,109.98 1,082.29 Short Term Loans & Adv. 193.13 290.49 259.99 236.02 202.29 146.86 9.99 190.34 1,109.75 1,069.70 Net Current Assets 492.31 565.09 580.34 621.46 622.53 788.26 1,059.20 852.68 848.87 821.31 Total Assets 2,026.09 2,199.10 1,237.04 2,017.88 2,113.13 2,070.38 1,424.54 2,060.45 2,005.94 1,953.13

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 38.67 -69.21 -23.14 -194.28 160.99 -40.83 56.59 -59.59 -4.56 7.43 PBT -3.82 40.04 28.64 85.77 157.52 91.73 111.37 99.56 89.90 169.42 Adjustment -5.64 -4.98 -11.80 -72.66 -55.87 -55.95 -67.04 -84.63 -74.44 -70.96 Changes in Working Capital 66.72 -69.08 -1.85 -161.76 117.30 -32.45 91.70 -31.81 10.76 -30.41 Cash after chg. in Working capital 57.26 -34.02 14.99 -148.65 218.95 3.33 136.03 -16.88 26.22 68.05 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -18.59 -35.19 -38.13 -45.63 -57.96 -44.16 -79.44 -36.38 -30.78 -60.62 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -6.33 0.00 0.00 Cash From Investing Activity 87.04 95.16 55.91 274.23 68.70 423.64 -630.47 718.94 22.16 -16.06 Net Fixed Assets 41.87 10.27 -61.15 -11.84 -1.26 -0.51 15.76 -2.10 2.03 -2.38 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02 0.00 0.00 Others 45.17 84.89 117.06 286.07 69.96 424.15 -646.24 721.02 20.13 -13.68 Cash from Financing Activity -35.63 -36.80 -41.41 -29.82 -267.65 -331.80 -38.57 -37.67 -37.79 -37.33 Net Cash Inflow / Outflow 90.08 -10.85 -8.64 50.13 -37.96 51.01 -612.45 621.68 -20.19 -45.96 Opening Cash & Equivalents 68.27 79.12 87.76 37.63 75.59 24.58 637.03 15.35 35.54 81.50 Closing Cash & Equivalent 158.35 68.27 79.12 87.76 37.63 75.59 24.58 637.03 15.35 35.54

Financial Ratios

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 281.17 289.36 293.36 309.34 299.76 329.45 375.63 313.51 300.80 281.67 ROA -0.18% 1.22% 0.62% 2.51% 3.75% 3.27% 11.38% 3.89% 4.98% 6.39% ROE -0.53% 2.91% 1.36% 6.89% 9.40% 5.38% 18.01% 8.06% 10.59% 13.94% ROCE 0.14% 6.67% 4.73% 11.70% 19.72% 8.75% 24.77% 9.52% 9.69% 19.74% Fixed Asset Turnover 9.03 5.68 9.77 32.72 59.76 63.43 38.38 34.93 34.80 36.80 Receivable days 31.23 30.70 28.50 27.72 22.59 25.31 35.20 33.46 33.71 30.68 Inventory Days 39.38 42.89 40.83 36.25 38.41 44.47 45.59 42.48 45.08 38.08 Payable days 130.52 159.09 74.34 84.28 68.27 44.09 50.69 46.89 53.76 52.77 Cash Conversion Cycle -59.90 -85.49 -5.01 -20.31 -7.27 25.70 30.10 29.04 25.04 15.99 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 0.21 6.21 5.48 54.94 29.48 128.40 1294.67 444.95 333.96 771.09

Top Investors:

investor education and protection fund (iepf)

Annual Reports:

News Update:

Novartis - Quarterly Results
8th Feb 2023, 18:11 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback